Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 99.275 USD -0.45%
Market Cap: 246.4B USD

During the last 3 months Merck & Co Inc insiders have not bought any shares, and sold 1.3m USD worth of shares. The stock price has increased by 19% over this period (open performance analysis).

The last transaction was made on Nov 10, 2025 by Downing Cristal N , who sold 616.4k USD worth of MRK shares.

Last Transactions:
Downing Cristal N
$-616.4k
Williams David Michael
$-720k
Smart Dalton E. Iii
$-352.7k
Oosthuizen Johannes Jacobus
$-714.7k
Williams David Michael
$-512.1k
Thulin Inge G
$+250k
Downing Cristal N
$-209.6k
Baker Douglas M Jr
$+1.3m
Litchfield Caroline
$-4.8m
Davis Robert M
$-10.7m
Romanelli Joseph
$-124.9k
Davis Robert M
$-15.7m
Li Dean Y
$-1.8m
Williams David Michael
$-185.1k
Oosthuizen Johannes Jacobus
$-2.4m
Mizell Steven
$-6.4m
Zachary Jennifer
$-6.3m
Oosthuizen Johannes Jacobus
$-213.1k
Deluca Richard R.
$-4.6m
Mizell Steven
$-463.3k
Mizell Steven
$-474.7k
Romanelli Joseph
$-3.2k
Zachary Jennifer
$-2.3m
Karachun Rita A
$-1.9m
Mizell Steven
$-1.5m
Williams David Michael
$-877.2k
Deluca Richard R.
$-8.8m
Deluca Richard R.
$-7.6m
Davis Robert M
$-16.5m
Romanelli Joseph
$+341
Chattopadhyay Sanat
$-7.6m
Romanelli Joseph
$-3.7k
View All Transactions

During the last 3 months Merck & Co Inc insiders have not bought any shares, and sold 1.3m USD worth of shares. The stock price has increased by 19% over this period (open performance analysis).

The last transaction was made on Nov 10, 2025 by Downing Cristal N , who sold 616.4k USD worth of MRK shares.

Sold
0-3
months
1.3m USD
2
3-6
months
0 USD
0
6-9
months
352.7k USD
1
9-12
months
1.4m USD
3
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
0
0 USD
9-12
months
2
1.6m USD

Merck & Co Inc
Insider Trading Chart

Merck & Co Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Merck & Co Inc
Last Insider Transactions

Global
Insiders Monitor

Merck & Co Inc
Glance View

Nestled in the heart of the pharmaceutical industry, Merck & Co., Inc. stands as a titan of innovation and healthcare. Established in 1891, the company has grown and evolved, driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. At the core of Merck’s operations is its commitment to research and development (R&D), which serves as the lifeblood of its product pipeline. With billions poured annually into R&D, Merck seeks to uncover new medical breakthroughs that address unmet medical needs across diverse therapeutic areas, such as oncology, vaccines, infectious diseases, and diabetes. This relentless pursuit of scientific advancement is not only a testament to Merck’s commitment to health but also a critical factor in maintaining its competitive edge in a crowded market. Merck's business model is elegantly straightforward yet highly structured. Primarily, the company's revenue streams are powered by the sales of prescription medications and vaccines that emerge from their exhaustive research efforts. Products like Keytruda, a cancer immunotherapy, and Gardasil, a vaccine for human papillomavirus, are standout performers, championing Merck's ability to penetrate high-value markets and secure regulatory approvals across the globe. Beyond the development and sale of pharmaceuticals, Merck generates additional revenue through collaborations and partnerships with other companies, leveraging co-development and marketing agreements to extend its reach. Underpinning Merck's financial model is its rigorous approach to cost management and strategic acquisitions, which bolster its robust product line-up and keep the engines of growth humming. This strategic orchestration ensures that while Merck fulfills its corporate mission, it also aligns with shareholder interests, reflecting a harmonious balance that has supported its storied legacy.

MRK Intrinsic Value
122.397 USD
Undervaluation 19%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top